These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1719416)

  • 21. Immunization of owl monkeys with a combination of Plasmodium falciparum asexual blood-stage synthetic peptide antigens.
    Ruebush TK2nd ; Campbell GH; Moreno A; Patarroyo ME; Collins WE
    Am J Trop Med Hyg; 1990 Oct; 43(4):355-66. PubMed ID: 2240363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards a malaria vaccine: what is in sight?
    del Giudice G
    Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children.
    Del Giudice G; Engers HD; Tougne C; Biro SS; Weiss N; Verdini AS; Pessi A; Degremont AA; Freyvogel TA; Lambert PH
    Am J Trop Med Hyg; 1987 Mar; 36(2):203-12. PubMed ID: 2435181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rhoptry antigen of Plasmodium falciparum is protective in Saimiri monkeys.
    Ridley RG; Takacs B; Etlinger H; Scaife JG
    Parasitology; 1990 Oct; 101 Pt 2():187-92. PubMed ID: 2263413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further studies on the immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax.
    Collins WE; Nussenzweig RS; Ruebush TK; Bathurst IC; Nardin EH; Gibson HL; Campbell GH; Barr PJ; Broderson JR; Skinner JC
    Am J Trop Med Hyg; 1990 Dec; 43(6):576-83. PubMed ID: 1702586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults.
    Sturchler D; Berger R; Rudin C; Just M; Saul A; Rzepczyk C; Brown G; Anders R; Coppel R; Woodrow G
    Am J Trop Med Hyg; 1995 Oct; 53(4):423-31. PubMed ID: 7485698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis for antibody recognition of the NANP repeats in
    Oyen D; Torres JL; Wille-Reece U; Ockenhouse CF; Emerling D; Glanville J; Volkmuth W; Flores-Garcia Y; Zavala F; Ward AB; King CR; Wilson IA
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10438-E10445. PubMed ID: 29138320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major population differences in T cell response to a malaria sporozoite vaccine candidate.
    Zevering Y; Houghten RA; Frazer IH; Good MF
    Int Immunol; 1990; 2(10):945-55. PubMed ID: 1706620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of recombinant vaccinia viruses expressing Plasmodium falciparum antigens to protect Saimiri monkeys against malaria.
    Pye D; Edwards SJ; Anders RF; O'Brien CM; Franchina P; Corcoran LN; Monger C; Peterson MG; Vandenberg KL; Smythe JA
    Infect Immun; 1991 Jul; 59(7):2403-11. PubMed ID: 1711015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria.
    Zavala F; Tam JP; Hollingdale MR; Cochrane AH; Quakyi I; Nussenzweig RS; Nussenzweig V
    Science; 1985 Jun; 228(4706):1436-40. PubMed ID: 2409595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates.
    Kubler-Kielb J; Majadly F; Biesova Z; Mocca CP; Guo C; Nussenzweig R; Nussenzweig V; Mishra S; Wu Y; Miller LH; Keith JM; Liu TY; Robbins JB; Schneerson R
    Proc Natl Acad Sci U S A; 2010 Jan; 107(3):1172-7. PubMed ID: 20080619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New B cell epitopes in the Plasmodium falciparum malaria circumsporozoite protein.
    Stüber D; Bannwarth W; Pink JR; Meloen RH; Matile H
    Eur J Immunol; 1990 Apr; 20(4):819-24. PubMed ID: 1693336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of Aotus monkeys from malaria infection by immunization with recombinant hybrid proteins.
    Knapp B; Hundt E; Enders B; Küpper HA
    Infect Immun; 1992 Jun; 60(6):2397-401. PubMed ID: 1587607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental basis for the development of a synthetic vaccine against Plasmodium falciparum malaria sporozoites.
    Nussenzweig V; Nussenzweig R
    Ciba Found Symp; 1986; 119():150-63. PubMed ID: 2426050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum.
    Etlinger HM; Caspers P; Matile H; Schoenfeld HJ; Stueber D; Takacs B
    Infect Immun; 1991 Oct; 59(10):3498-503. PubMed ID: 1894356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sporozoite malaria vaccine. Where do we stand?
    Nussenzweig V; Nussenzweig S
    Ann Parasitol Hum Comp; 1990; 65 Suppl 1():49-52. PubMed ID: 1702271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of human volunteer sera to candidate Plasmodium falciparum circumsporozoite protein vaccines in the inhibition of sporozoite invasion assay of human hepatoma cells and hepatocytes.
    Hollingdale MR; Appiah A; Leland P; do Rosario VE; Mazier D; Pied S; Herrington DA; Chulay JD; Ballou WR; Derks T
    Trans R Soc Trop Med Hyg; 1990; 84(3):325-9. PubMed ID: 2175464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of antibodies to Plasmodium falciparum sporozoites by employing synthetic peptides.
    Del Giudice G; Biro S; Degrémont AA; Engers HD; Lambert PH; Pessi A; Tougne C; Verdini AS; Weiss N; Tanner M
    Parassitologia; 1986; 28(2-3):107-11. PubMed ID: 3332303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
    Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL
    J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.
    Herrington DA; Clyde DF; Losonsky G; Cortesia M; Murphy JR; Davis J; Baqar S; Felix AM; Heimer EP; Gillessen D
    Nature; 1987 Jul 16-22; 328(6127):257-9. PubMed ID: 2439920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.